登录 注册 会员服务 联系我们

Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus

  • Published:2016-03-31 Issue:4 Volume:36 Page:672-704
  • ISSN:0198-6325
  • Container-title:Medicinal Research Reviews
  • language:en
  • Short-container-title:Med. Res. Rev.

Author:

So Wing Yan1,Leung Po Sing1

Affiliation:

1. School of Biomedical Sciences, Faculty of Medicine; the Chinese University of Hong Kong; Shatin Hong Kong China

Funder

Research Grants Council of the Hong Kong Special Administrative Region, China

Publisher

Wiley

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Reference186 articles.

1. World Health Organization 2015 http: //www.who.int/mediacentre/factsheets/fs312/en/index.html

2. FGF-21 as a novel metabolic regulator;Kharitonenkov;J Clin Invest,2005

3. Fibroblast growth factor 21 corrects obesity in mice;Coskun;Endocrinology,2008

4. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice;Xu;Diabetes,2009

5. Actions and mode of actions of FGF19 subfamily members;Fukumoto;Endocr J,2008
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3